Toggle navigation
Home
Search
Services
Blog
Contact
About
A Novel Approach to Polymeric Narcotic Antagonists
Kim, Sung Wan
University of Utah, Salt Lake City, UT, United States
Search 234 grants from Sung Kim
Search grants from University of Utah
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
Identifying Vitamin K Dependent Pathways in Osteoarthritis Progression
Bioenergetics Core
Improving HIV/AIDS/Sti/Tb Related Public Health Practice & Servie Delivery
Pathogenesis and Treatment of Chronic Rejection
Recently added grants:
Enhancing Breast Tumor Cell Immunogenicity by Targeting the Epigenetic Factor NURF
Imaging neuromodulation in the brain
Membrane Trafficking of Opioid and Adrenergic Receptors
Comparative Pharmacology of Cannabinoids in Rodent Models
Extrahypothalamic PPARs and compulsive food intake
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA002391-03S1
Application #
3207293
Study Section
(DABB)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
University of Utah
Department
Type
Schools of Pharmacy
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Related projects
NIH 1986
R01 DA
A Novel Approach to Polymeric Narcotic Antagonists
Kim, Sung Wan / University of Utah
NIH 1986
R01 DA
A Novel Approach to Polymeric Narcotic Antagonists
Kim, Sung Wan / University of Utah
NIH 1985
R01 DA
A Novel Approach to Polymeric Narcotic Antagonists
Kim, Sung Wan / University of Utah
Publications
Negishi, N; Bennett, D B; Cho, C S et al.
(1987)
Coupling of naltrexone to biodegradable poly(alpha-amino acids).
Pharm Res 4:305-10
Comments
Be the first to comment on this grant